CI (The Cigna Group) ROCE %: % (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CI The Cigna Group CI
74 GF Score
Price $274.47
GF Value $394.34
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is The Cigna Group ROCE %?

The Cigna Group CI -0.29% 74 ROCE % is % as of Jun. 2026. GuruFocus rates CI with a GF Score™ of 74/100 and a GF Value™ of $394.34 (Significantly Undervalued). The stock has 4 warning signs investors should review.

ROCE % does not apply to banks and insurance companies.

CI
74GF Score
The Cigna Group CI
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of % mean?
The Cigna Group (CI) has a ROCE % of % as of Jun. 2026.
Is The Cigna Group's ROCE % too high?
The Cigna Group's current ROCE % is %. Overall, The Cigna Group has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's ROCE % compare to ELV and HUM?
The Cigna Group's ROCE % of % can be compared against companies in the Healthcare Plans industry. The industry median ROCE % is 10.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Plans company?
The median ROCE % among Healthcare Plans companies is 10.12, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median ROCE % is 10.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cigna Group's current ROCE % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
Based on GuruFocus' analysis, The Cigna Group (CI) is currently considered Significantly Undervalued. The stock's GF Value™ is $394.34, compared to a current price of $274.47 — trading 30.4% below its estimated fair value. The current ROCE % is %. The Cigna Group's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For The Cigna Group (CI), the current ROCE % is % as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cigna Group (CI) Overvalued in 2026?

Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued. The current stock price of $274.47 is trading 30.4% below its estimated GF Value™ of $394.34. GuruFocus considers The Cigna Group to be Significantly Undervalued.

Key valuation signals for CI:

  • ROCE %: %
  • GF Value™: $394.34 vs. price of $274.47 (30.4% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the CI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cigna Group Business Description

Address 900 Cottage Grove Road, Bloomfield, CT, USA, 06002
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
74GF Score

Get the complete analysis for CI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$274.47
Price
$394.34
GF Value